Purdue Case Could Transform Patent Obviousness Analyses
By Tanya D'Souza and William Scofield · July 9, 2025, 5:35 PM EDT
A pending petition for certiorari to the U.S. Supreme Court by Purdue Pharma could significantly shift how courts weigh secondary considerations in patent obviousness analyses. In this analysis, we explore the...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login